BTG PLC (BTG.L)

BTG.L on London Stock Exchange

662.00GBp
19 Sep 2014
Price Change (% chg)

4.50p (+0.68%)
Prev Close
657.50p
Open
668.00p
Day's High
671.00p
Day's Low
659.00p
Volume
791,446
Avg. Vol
444,265
52-wk High
671.10p
52-wk Low
365.30p

BTG.L

Chart for BTG.L

About

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are... (more)

Overall

Beta: 0.36
Market Cap (Mil.): £2,400.67
Shares Outstanding (Mil.): 362.64
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 96.53 32.84 33.70
EPS (TTM): 0.07 -- --
ROI: 4.41 18.11 17.35
ROE: 5.04 18.82 18.21
Search Stocks

BRIEF-BTG receives FDA nod for pulmonary embolism treatment

* Ekosonic endovascular system receives FDA clearance for treatment of pulmonary embolism in USA Source text for Eikon: Further company coverage:

23 May 2014

BRIEF-BTG full-year pretax profit rises 38 pct

* FY pretax profit 33.3 million stg versus 24.1 million stg year ago

20 May 2014

BRIEF-BTG sees year revenue around top end of guidance range

LONDON, April 3 - BTG plc update for the year ended 31 March 2014:

03 Apr 2014

Earnings vs. Estimates

Search Stocks